p53-independent induction of WAF1/Cip1 is correlated with osteoblastic differentiation by vitamin D3

Cancer Letters

Volumn 129, Issue 1, 1998, Pages 61-68

  Matsumoto, Takuji ^a   Sowa, Yoshihiro ^b   Ohtani Fujita, Naoko ^b   Tamaki, Tetsuya ^a   Takenaka, Toru ^a   Kuribayashi, Koichi ^a   Sakai, Toshiyuki ^b  

^a WAKAYAMA MEDICAL UNIVERSITY   (Japan)

^b KYOTO PREFECTURAL UNIVERSITY OF MEDICINE   (Japan)

Author keywords

1 ,25(OH)2 vitamin D3; Differentiation; Osteoblasts; RB; WAF1 Cip1

Indexed keywords

ALKALINE PHOSPHATASE; CALCITRIOL; COLECALCIFEROL; CYCLIN DEPENDENT KINASE; CYCLIN DEPENDENT KINASE INHIBITOR; MESSENGER RNA; PROTEIN P53; RETINOBLASTOMA PROTEIN;

ARTICLE; CELL CYCLE G1 PHASE; CELL DIFFERENTIATION; CONTROLLED STUDY; GENE INDUCTION; HUMAN; HUMAN CELL; OSTEOBLAST; OSTEOSARCOMA; PRIORITY JOURNAL; PROMOTER REGION; PROTEIN PHOSPHORYLATION; TUMOR SUPPRESSOR GENE;

CALCITRIOL; CELL DIFFERENTIATION; CYCLIN-DEPENDENT KINASE INHIBITOR P21; CYCLINS; GENE EXPRESSION REGULATION; GENES, P53; HUMANS; OSTEOBLASTS; PROMOTER REGIONS (GENETICS); RETINOBLASTOMA PROTEIN; RNA, MESSENGER; TUMOR CELLS, CULTURED;

EID: 0032479564     PISSN: 03043835     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0304-3835(98)00080-9     Document Type: Article

References (47)

1. Andrianarivo A.G., Robinson J.A., Mann K.G., Tracy R.P. Growth on type I collagen promotes expression of the osteoblastic phenotype in human osteosarcoma MG-63 cells. J. Cell Physiol. 153:1992;256-265.
2. Biggs J.R., Kudlow J.E., Kraft A.S. The role of the transcription factor Sp1 in regulating the expression of the WAF1/CIP1 gene in U937 leukemic cells. J. Biol. Chem. 271:1996;901-906.
3. 3 on differentiation of a human osteosarcoma (MG-63). J. Biol. Chem. 267:1992;8943-8949.
4. Brasier A.R., Tate J.E., Habener J.F. Optimized use of the firefly luciferase assay as a reporter gene in mammalian cell lines. BioTechniques. 7:1989;1116-1122.
5. Chandar N., Billig B., McMaster J., Novak J. Inactivation of p53 gene in human and murine osteosarcoma cells. Br. J. Cancer. 65:1992;208-214.
6. Chin Y.E., Kitagawa M., Su W.C., You Z.H., Iwamoto Y., Fu X.Y. Cell growth arrest and induction of cyclin-dependent kinase inhibitor p21 WAF1/CIP1 mediated by STAT1. Science. 272:1996;719-722.
7. Coppola J.A., Lewis B.A., Cole M.D. Increased retinoblastoma gene expression is associated with late stages of differentiation in many different cell types. Oncogene. 5:1990;1731-1733.
8. Datto M.B., Yu Y., Wang X.F. Functional analysis of the transforming growth factor beta responsive elements in the WAF1/Cip1/p21 promoter. J. Biol. Chem. 270:1995;28623-28628.
9. Dehar S. Signal transduction via the β1 integrins is a required intermediate in interleukin-1β induction of alkaline phosphatase activity in human osteosarcoma cells. Exp. Cell Res. 183:1989;207-214.
10. El-Deiry W.S., Tokino T., Velculescu V.E., Levy D.B., Parsons R., Trent J.M., Lin D., Mercer W.E., Kinzler K.W., Vogelstein B. WAF1, a potential mediator of p53 tumor suppression. Cell. 75:1993;817-825.
11. Evans P.M. The steroid and thyroid hormone receptor superfamily. Science. 240:1988;889-895.
12. Fan J., Bertino J.R. Functional roles of E2F in cell cycle regulation. Oncogene. 14:1997;1191-1200.
13. Friend S.H., Bernards R., Rogelj S., Weinberg R.A., Rapaport J.M., Albert D.M., Dryja T.P. A human DNA segment with properties of the gene that predisposes to retinoblastoma and osteosarcoma. Nature. 323:1986;643-646.
14. Goodrich D.W., Wang N.P., Qian Y.W., Lee E.Y., Lee W.H. The retinoblastoma gene product regulates progression through the G1 phase of the cell cycle. Cell. 67:1991;293-302.
15. Goodrich D.W., Lee W.-H. Molecular characterization of the retinoblastoma susceptibility gene. Biochim. Biophys. Acta. 1155:1993;43-61.
16. Gope R., Gope M.L. Effect of sodium butyrate on the expression of retinoblastoma (RB1) and p53 genes and phosphorylation of retinoblastoma protein in human colon tumor cell line HT-29. Cell. Mol. Biol. 39:1993;589-597.
17. Gu W., Schneider J.W., Condorelli G., Kaushal S., Mahdavi V., Nadal-Ginard B. Interaction of myogenic factors and the retinoblastoma protein mediates muscle cell commitment and differentiation. Cell. 72:1993;309-324.
18. Gu Y., Turck C.W., Morgan D.O. Inhibition of CDK2 activity in vivo by an associated 20K regulatory subunit. Nature. 366:1993;707-710.
19. Halevy O., Novitch B.G., Spicer D.B., Skapek S.X., Rhee G.J., Hannon G.J., Beach D., Lasser A.B. Correlation of terminal cell cycle arrest of skeletal muscle with induction of p21 by MyoD. Science. 267:1995;1018-1021.
20. Harper J.W., Adami G.R., Wei N., Keyomarsi K., Elledge S.J. The p21 cdk-interacting protein Cip1 is a potent inhibitor of G1 cyclin-dependent kinases. Cell. 75:1993;805-816.
21. Hinds P.W., Mittnacht S., Dulic V., Arnold A., Reed S.I., Weinberg R.A. Regulation of retinoblastoma protein functions by ectopic expression of human cyclins. Cell. 70:1992;993-1006.
22. Hill P.A., Reynolds J.J., Meikle M.C. Osteoblasts mediate insulin-like growth factor-I and -II stimulation of osteoclast formation and function. Endocrinology. 136:1995;124-131.
23. Horowitz J.M., Park S.-H., Bogenmann E., Cheng J.-C., Yandell D.W., Kaye F.J., Minna J.D., Dryja T.P., Weinberg R.A. Frequent inactivation of the retinoblastoma anti-oncogene is restricted to a subset of human tumor cells. Proc. Natl. Acad. Sci. USA. 87:1990;2775-2779.
24. Huang H.J., Yee J.K., Shew J.Y., Chen P.L., Bookstein R., Friedmann T., Lee E.Y., Lee W.H. Suppression of the neoplastic phenotype by replacement of the RB gene in human cancer cells. Science. 242:1988;1563-1566.
25. Jiang H., Lin J., Su Z.-Z., Collert E., Hubermann E., Fisher P.B. Induction of differentiation in human promyelocytic HL60 leukemia cells activates p21, WAF1/CIP1, expression in the absence of p53. Oncogene. 9:1994;3397-3406.
26. Kobayashi T., Hashimoto K., Yoshikawa K. Dephosphorylation of the retinoblastoma gene product induced by differentiation and its relevancy to growth inhibition in normal human keratinocytes. J. Dermatol. Sci. 8:1994;171-177.
27. 3 leads to the induced differentiation of the myelomonocytic cell line U937. Genes Dev. 10:1996;142-153.
28. Mahonen A., Maenpaa P.H. Steroid hormone modulation of vitamin D receptor levels in human MG-63 osteosarcoma cells. Biochem. Biophys. Res. Commun. 205:1994;1179-1186.
29. Majeska R.J., Rodan G.A. Alkaline phosphatase inhibition by parathyroid hormone and isoproterenol in a clonal rat osteosarcoma cell line. Possible mediation by cyclic AMP. Calcif. Tissue Int. 34:1982;59-66.
30. Michieli P., Chedid M., Lin D., Pierce J.H., Mercer W.E., Givol D. Induction of WAF1/Cip1 by a p53-independent pathway. Cancer Res. 54:1994;3391-3395.
31. Missero C., Calautti E., Eckner R., Chin J., Tsai L.H., Livingston D.M., Dotto G.P. Involvement of the cell-cycle inhibitor Cip1/WAF1 and the E1A-associated p300 protein in terminal differentiation. Proc. Natl. Acad. Sci. USA. 92:1995;5454-5455.
32. Murakami T., Takahashi H., Akiya S., Higashi K. Effects of dibutyryl cyclic AMP on the gene expression during the differentiation of retinoblastoma cells (Y79) in culture. Acta Soc. Ophthalmol. Jpn. 97:1993;703-707.
33. Nakano K., Mizuno T., Sowa Y., Orita T., Yoshino T., Okuyama Y., Fujita T., Ohtani Fujita N., Matsukawa Y., Tokino T., Yamagishi H., Oka T., Nomura H., Sakai T. Butyrate activates the WAF1/Cip1 gene promoter through Sp1 sites in a p53-negative human colon cancer cell line. J. Biol. Chem. 272:1997;22199-22206.
34. Noda A., Ning Y., Venable S.F., Pereira-Smith O.M., Smith J.R. Cloning of senescent cell-derived inhibitors of DNA synthesis using an expression screen. Exp. Cell Res. 211:1994;980-989.
35. Ohshima T. Role of tumor suppressor genes in human osteosarcoma cells. Kokubyo-Gakkai Zasshi. 58:1991;300-318.
36. Pirskanen A., Jaaskelainen T., Maenpaa P.H. Insulin-like growth factor-1 modulates steroid hormone effects on osteocalcin synthesis in human MG-63 osteosarcoma cells. Eur. J. Biochem. 218:1993;883-891.
37. 3-induced osteocalcin synthesis in human osteosarcoma cells by other steroidal hormones. Mol. Cell. Endocrinol. 76:1991;149-159.
38. 3 increases synthesis of the vitamin K-dependent bone protein by osteosarcoma cells. J. Biol. Chem. 255:1980;11660-11663.
39. Reichel H., Koeffer H.P., Norman A.W. The role of the vitamin D endocrine system in health and disease. N. Engl. J. Med. 320:1989;980-991.
40. T.K. Ross, H.M. Darwish, H.F. DeLuca, Molecular biology of vitamin D action, in: G. Litwak (Ed.), Vitamins and Hormones, Academic Press, San Diego, CA, 1994, pp. 281-326.
41. Sakai T., Ohtani N., McGee T.L., Robbins P.D., Dryja T.P. Oncogenic germ-line mutations in Sp1 and ATF sites in the human retinoblastoma gene. Nature. 353:1991;83-86.
42. J. Sambrook, E.F. Fritsch, T. Maniatis, Molecular Cloning: A Laboratory Manual, second ed., Cold Spring Harbor Laboratory Press, Cold Spring Harbor, NY, 1989.
43. Slack R.S., Hamel P.A., Bladon T.S., Gill R.M., McBurney M.W. Regulated expression of the retinoblastoma gene in differentiating embryonal carcinoma cells. Oncogene. 8:1993;1585-1591.
44. Sowa Y., Orita T., Minamikawa S., Nakano K., Mizuno T., Nomura H., Sakai T. Histone deacetylase inhibitor activates the WAF1/Cip1 gene promoter through the Sp1 sites. Biochem. Biophys. Res. Commun. 241:1997;142-150.
45. Xiong Y., Hannon G.J., Zhang H., Casso D., Kobayashi R., Beach D. p21 is a universal inhibitor of cyclin kinases. Nature. 366:1993;701-704.
46. Yen A., Varvayanis S., Platko J.D. 12-O-tetradecanoylphorbol-13-acetate and staurosporine induce increased retinoblastoma tumor suppressor gene expression with megakaryocytic differentiation of leukemic cells. Cancer Res. 53:1993;3085-3091.
47. Yen A., Chandler S., Forbes M.E., Fung Y.K., T'Ang A. Coupled down-regulation of the RB retinoblastoma and c-myc genes antecedes cell differentiation: possible role of RB as a 'status quo' gene. Eur. J. Cell Biol. 57:1992;210-221.